WallStreetZenWallStreetZen

NASDAQ: PBM
Psyence Biomedical Ltd Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Psyence Biomedical earnings were $1.0M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest PBM earnings report on Mar 31, 2025 announced Q1 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Mar 31, 2025, PBM reported annual earnings of $1.0M, with -102% growth.

PBM past earnings growth

How has PBM's earnings growth performed historically?

Company
N/A
Industry
11.23%
Market
34.13%
PBM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
PBM's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

PBM earnings history

Current Revenue
$0.0
Current Earnings
$1.0M
Current Profit Margin
0%

PBM Return on Equity

Current Company
-47.6%
Current Industry
-60.2%
Current Market
31.3%
PBM's Return on Equity (-47.6%)... subscribe to Premium to read more.
High Return on Equity Performance

PBM undefined

Current Company
24%
Current Industry
-2.5%
PBM is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when PBM announces earnings.

PBM undefined

Current Company
15.19%
Current Industry
5.8%
PBM's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

PBM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
PBM$1.03M$1.01M-99.60%$5.24
GLMD-$7.82M-$7.35MN/A-$7.06
ELAB-$5.74M-$6.46MN/A$27.77
GRI-$9.38M-$11.28MN/A-$78.52
ENVB-$8.96M-$9.30MN/A-$13.36
View Top Biotech Stocks

Psyence Biomedical Earnings Reports & History FAQ

What were Psyence Biomedical's earnings last quarter?

Psyence Biomedical (NASDAQ: PBM) reported Q1 2025 earnings per share (EPS) of N/A, up N/A year over year. Total PBM earnings for the quarter were N/A. In the same quarter last year, Psyence Biomedical's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Psyence Biomedical stock.

Is Psyence Biomedical profitable or losing money?

As of the last Psyence Biomedical earnings report, Psyence Biomedical is currently profitable. Psyence Biomedical's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.01 million, a 101.98% decrease year over year.

What was PBM's earnings growth in the past year?

As of Psyence Biomedical's earnings date in Q3 2025, Psyence Biomedical's earnings has grown year over year. PBM earnings in the past year totalled $1.01 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.